Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if TLRY is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
24 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 68 days ago
Red flags: 0
238 filers reported a long position in TLRY for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Tidal Investments LLC | $11.2M | 2.5M | -2.5% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.6M | 1M | +88.4% |
| MORGAN STANLEY | $4.5M | 995.1K | +55.2% |
| CITADEL ADVISORS LLC | $3.9M | 868.1K | +6,142.1% |
| Point72 Asset Management, L.P. | $2.9M | 648.5K | New |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $2.9M | 646.8K | +32.9% |
| AQR CAPITAL MANAGEMENT LLC | $2.3M | 512.6K | +14.5% |
| BlackRock, Inc. | $2.1M | 461.7K | +9.2% |
| UBS Group AG | $2M | 454.2K | -30.4% |
| LAZARD ASSET MANAGEMENT LLC | $1.8M | 394.7K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.